Filing metadata

Accession number
0000950170-23-046801
Form type
Form 4
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Sep 06, 2023
Reporting period
Sep 01, 2023
Description
Insider transaction

Explore SEC Filings Hub